CRVS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Corvus Pharmaceuticals presents final Phase 1/1b data from soquelitinib T cell lymphoma trialDec 9, 2025
- Corvus Pharmaceuticals announces partner Angel Pharmaceuticals received IND approval for Phase 1b/2 trial of Soquelitinib in China for atopic dermatitisJun 25, 2025
- Corvus presents Soquelitinib preclinical data showing ITK inhibition potential in systemic sclerosis at EULAR 2025Jun 11, 2025
- Corvus Pharmaceuticals releases full data from Phase 1 placebo-controlled trial of Soquelitinib for atopic dermatitisJun 4, 2025